Table 1 Comparison of clinicopathological data of different FAR groups
From: Prospective evaluation of hematological parameters in preoperative renal cell cancer patients
Features | Total | Preoperative FAR | P value | |
|---|---|---|---|---|
 ≤ 0.114 (n = 53) |  > 0.114 (n = 19) | |||
Age | Â | Â | Â | 0.938 |
 ≤ 65 years | 50 (69.4) | 34(73.9) | 12 (26.1) |  |
 > 65 years | 22 (30.6) | 19(73.1) | 7(26.9) |  |
Gender | Â | Â | Â | 0.746 |
 Male | 55 (76.4) | 41 (74.5) | 14 (25.5) |  |
 Female | 17 (23.6) | 12 (70.6) | 5 (29.4) |  |
Fuhrman grade |  |  |  |  < 0.0001 |
 I–II | 61 (84.7) | 52(85.2) | 9(14.8) |  |
 III–IV | 11 (15.3) | 1 (9.1) | 10 (90.9) |  |
Pathological T stage |  |  |  |  < 0.0001 |
 pT1–2 | 61 (84.7) | 52 (85.2) | 9(14.8) |  |
 pT3–4 | 11 (15.3) | 1(9.1) | 10(90.9) |  |
Histology | Â | Â | Â | Â |
 Clear cell carcinoma | 72 (100.0) | 53 (73.6) | 19 (26.4) |  |
 Non clear cell carcinoma | 0 (0.0) | 0 (0.0) | 0 (0.0) |  |
Case survıval |  |  |  |  < 0,0001 |
 Exitus | 6 ( 8.3) | 0 (0.0) | 6 |  |
 Alive | 66 ( 91.7) | 53 | 13 |  |